Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleNew Atypical Antipsychotic.AuthorsVoelker, RebeccaAbstractThe article reports that the U.S. Food and Drug Administration (FDA) has approved the Vyaler, a marketed atypical antipsychotic cariprazine used in treating adults with schizophrenia and bipolar disorder.PublicationJAMA: Journal of the American Medical Association, 2015, Vol 314, Issue 17, p1789ISSN0098-7484Publication typeArticleDOI10.1001/jama.2015.14005